Annual Secretarial Compliance Report for year ended 31/03/2025
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Life Sciences has filed its Annual Secretarial Compliance Report for the financial year ended 31 March 2025 with BSE and NSE. The report was certified by Practicing Company Secretary D. Renuka under SEBI (LODR) Regulation 24A. It covers the company's compliance with multiple SEBI regulations including LODR, Insider Trading, and Takeover norms. The company received a clean compliance status across all 14 parameters reviewed — secretarial standards, board policies, website disclosures, related party transactions, insider trading database, and performance evaluation. No deviations, fines, SEBI actions, or auditor resignations were reported during the review period.
This is a routine annual regulatory filing with no material impact on shareholders or the stock price. It simply confirms the company has met all SEBI listing compliance requirements for FY25 with no penalties or adverse observations.